Literature DB >> 32188632

Lymphatics in bone arise from pre-existing lymphatics.

Marco Monroy1, Anna L McCarter1, Devon Hominick1, Nina Cassidy1, Michael T Dellinger2,3.   

Abstract

Bones do not normally have lymphatics. However, individuals with generalized lymphatic anomaly (GLA) or Gorham-Stout disease (GSD) develop ectopic lymphatics in bone. Despite growing interest in the development of tissue-specific lymphatics, the cellular origin of bone lymphatic endothelial cells (bLECs) is not known and the development of bone lymphatics has not been fully characterized. Here, we describe the development of bone lymphatics in mouse models of GLA and GSD. Through lineage-tracing experiments, we show that bLECs arise from pre-existing Prox1-positive LECs. We show that bone lymphatics develop in a stepwise manner where regional lymphatics grow, breach the periosteum and then invade bone. We also show that the development of bone lymphatics is impaired in mice that lack osteoclasts. Last, we show that rapamycin can suppress the growth of bone lymphatics in our models of GLA and GSD. In summary, we show that bLECs can arise from pre-existing LECs and that rapamycin can prevent the growth of bone lymphatics.
© 2020. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Generalized lymphatic anomaly; Gorham-Stout disease; PIK3CA; Rapamycin; VEGF-C

Mesh:

Substances:

Year:  2020        PMID: 32188632      PMCID: PMC7188445          DOI: 10.1242/dev.184291

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  36 in total

1.  VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.

Authors:  Qian Zhang; Ruolin Guo; Yan Lu; Lan Zhao; Quan Zhou; Edward M Schwarz; Jing Huang; Di Chen; Zheng-Gen Jin; Brendan F Boyce; Lianping Xing
Journal:  J Biol Chem       Date:  2008-03-20       Impact factor: 5.157

2.  Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects.

Authors:  Xu-Ming Dai; Gregory R Ryan; Andrew J Hapel; Melissa G Dominguez; Robert G Russell; Sara Kapp; Vonetta Sylvestre; E Richard Stanley
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

Review 3.  Viewpoints on vessels and vanishing bones in Gorham-Stout disease.

Authors:  Michael T Dellinger; Nupur Garg; Bjorn R Olsen
Journal:  Bone       Date:  2014-02-26       Impact factor: 4.398

4.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene.

Authors:  H Yoshida; S Hayashi; T Kunisada; M Ogawa; S Nishikawa; H Okamura; T Sudo; L D Shultz; S Nishikawa
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

5.  Sirolimus in the Treatment of Vascular Anomalies.

Authors:  Paloma Triana; Mariela Dore; Vanesa Nuñez Cerezo; Manuel Cervantes; Alejandra Vilanova Sánchez; Miriam Miguel Ferrero; Mercedes Díaz González; Juan Carlos Lopez-Gutierrez
Journal:  Eur J Pediatr Surg       Date:  2016-10-10       Impact factor: 2.191

6.  Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.

Authors:  Marja Lohela; Hanna Heloterä; Paula Haiko; Daniel J Dumont; Kari Alitalo
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

7.  VEGF-C promotes the development of lymphatics in bone and bone loss.

Authors:  Devon Hominick; Asitha Silva; Noor Khurana; Ying Liu; Paul C Dechow; Jian Q Feng; Bronislaw Pytowski; Joseph M Rutkowski; Kari Alitalo; Michael T Dellinger
Journal:  Elife       Date:  2018-04-05       Impact factor: 8.140

8.  PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations.

Authors:  Hannah Blesinger; Silke Kaulfuß; Thiha Aung; Sonja Schwoch; Lukas Prantl; Jochen Rößler; Jörg Wilting; Jürgen Becker
Journal:  PLoS One       Date:  2018-07-09       Impact factor: 3.240

9.  LYVE1 Marks the Divergence of Yolk Sac Definitive Hemogenic Endothelium from the Primitive Erythroid Lineage.

Authors:  Lydia K Lee; Yasamine Ghorbanian; Wenyuan Wang; Yanling Wang; Yeon Joo Kim; Irving L Weissman; Matthew A Inlay; Hanna K A Mikkola
Journal:  Cell Rep       Date:  2016-11-22       Impact factor: 9.423

10.  Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly.

Authors:  Lara Rodriguez-Laguna; Noelia Agra; Kristina Ibañez; Gloria Oliva-Molina; Gema Gordo; Noor Khurana; Devon Hominick; María Beato; Isabel Colmenero; Gonzalo Herranz; Juan M Torres Canizalez; Rebeca Rodríguez Pena; Elena Vallespín; Rubén Martín-Arenas; Ángela Del Pozo; Cristina Villaverde; Ana Bustamante; Carmen Ayuso; Pablo Lapunzina; Juan C Lopez-Gutierrez; Michael T Dellinger; Victor Martinez-Glez
Journal:  J Exp Med       Date:  2018-12-27       Impact factor: 14.307

View more
  7 in total

1.  Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics.

Authors:  Juana Serrano-Lopez; Shailaja Hegde; Sachin Kumar; Josefina Serrano; Jing Fang; Ashley M Wellendorf; Paul A Roche; Yamileth Rangel; Leolene J Carrington; Hartmut Geiger; H Leighton Grimes; Sanjiv Luther; Ivan Maillard; Joaquin Sanchez-Garcia; Daniel T Starczynowski; Jose A Cancelas
Journal:  Elife       Date:  2021-04-08       Impact factor: 8.713

Review 2.  The evolving cardiac lymphatic vasculature in development, repair and regeneration.

Authors:  Konstantinos Klaourakis; Joaquim M Vieira; Paul R Riley
Journal:  Nat Rev Cardiol       Date:  2021-01-18       Impact factor: 49.421

Review 3.  Lymphatic Vessel Regression and Its Therapeutic Applications: Learning From Principles of Blood Vessel Regression.

Authors:  Faisal Masood; Rohan Bhattaram; Mark I Rosenblatt; Andrius Kazlauskas; Jin-Hong Chang; Dimitri T Azar
Journal:  Front Physiol       Date:  2022-03-22       Impact factor: 4.755

Review 4.  Osteopathy in Complex Lymphatic Anomalies.

Authors:  Ernesto Solorzano; Andrew L Alejo; Hope C Ball; Joseph Magoline; Yusuf Khalil; Michael Kelly; Fayez F Safadi
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

5.  Systematic lymphatic abnormality-related osseous lesions: a study based on CT lymphangiography.

Authors:  Yan Zhang; Xiaoli Sun; Wenbin Shen; Kun Hao; Qi Hao; Xingpeng Li; Rengui Wang
Journal:  Quant Imaging Med Surg       Date:  2022-09

6.  Bone development and fracture healing is normal in mice that have a defect in the development of the lymphatic system.

Authors:  A L McCarter; A Khalid; J J Rios; M T Dellinger; Y Yi; M Monroy; H Zhao
Journal:  Lymphology       Date:  2020       Impact factor: 1.286

7.  KRAS-driven model of Gorham-Stout disease effectively treated with trametinib.

Authors:  Nassim Homayun-Sepehr; Anna L McCarter; Raphaël Helaers; Christine Galant; Laurence M Boon; Pascal Brouillard; Miikka Vikkula; Michael T Dellinger
Journal:  JCI Insight       Date:  2021-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.